MFMarjan Fallah

Marjan Fallah

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marjan Fallah has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Milad Moloudizargari

    Department of Immunology, School of Medicine, Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    2 shared publications
  • Abbas Mohammadpour

    Cell and Molecular Biology, Pharmaceutical Sciences Research Center, Mazandaran University of Medical Sciences, Sari, Iran

    1 shared publication
  • Ali Akbar Moghadamnia

    Pharmaceutical Sciences Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran

    1 shared publication
  • Ali Ziar

    Department of Toxicology and Pharmacology, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran

    1 shared publication
  • Arman Khavand

    Department Of Pharmacy, Am.C., Islamic Azad University, Amol, Iran

    1 shared publication
  • Atefeh Mirshafa

    Department of Toxicology and Pharmacology, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran

    1 shared publication

Latest Publications

  • Fast and Sensitive Electrochemical Detection of Antiviral Drug Oseltamivir Based on Graphene/MXene Nanohybrid

    by Arman Khavand, Marjan Fallah, Fereshteh Chekin

    Introduction: Influenza virus belongs to the Orthomyxovirus family. This singlestranded RNA virus causes seasonal outbreaks with high morbidity and mortality. Oseltamivir (OST) is effective in the prevention and treatment of epidemic influenza. Hence, studying the electrochemical properties of OST is of interest. Methods: In this work, a low-cost graphene/MXene (Gr/MX) composite-modified carbon paste electrode (CPE) was used to detect OST. The Gr/MX was fabricated using the sonication method. The Gr/MX modified CPE detects OST well in phosphate buffer solution (PBS) at pH 7.0. Results: The electro-oxidation peak of the OST drug appeared at ~1.01 V. The wide linear sensing range (0.2-7.0 μM) and low detection limit (0.08 μM) with high sensitivity (28.26 μA μM-1 cm-2) for OST were determined by square-wave voltammetry. The results confirm that the synthesized novel Gr/MX nanohybrid exhibits excellent electrocatalytic activity towards OST with good selectivity, repeatability, reproducibility, and stability. The cost-effective Gr/MX/CPE sensor was successfully applied to measure OST in plasma and urine. Discussion: The synergistic enhancement to the detection of OST resulted from the large active surface area, high conductivity, and rapid electron transfer rate of Gr, which promoted electrocatalytic activity with the assistance of the MX nanostructure. Conclusion: The Gr/MX hybrid platform can be applied in clinical analysis laboratories and industry quality control for the determination of OST.

  • Identification of a novel cisplatin resistance gene in bladder cancer and potential inhibitors

    by Kiarash Zohori Pour, Marjan Fallah, Shirin Hekmatirad

    Cisplatin-based regimens are indicated for the treatment of a broad spectrum of solid malignancies. Bladder cancer is among the solid malignancies in which cisplatin is used as the first-line treatment. Despite the high success rate of cisplatin therapy, a subset of patients experience poor prognosis and develop resistance to cisplatin. For this reason, there is still a need to find new drug targets to overcome cisplatin resistance and improve response in patients with bladder cancer. This study aimed to find a potential target to help restore bladder cancer sensitivity to cisplatin. First, two microarray datasets were analyzed to find the gene signatures related to cisplatin resistance. Akinase anchor protein 5 (AKAP5) gene was selected as a possible target in cisplatin resistance. To find a suitable AKAP5 inhibitor, a virtual screening of a FDA-approved library was performed and 5-methyltetrahydrofolate (5-MTHF) was selected for the subsequent investigation. Finally, the effect of AKAP inhibition on the cytotoxicity of cisplatin in 5637 cells was determined using the MTT assay. Molecular docking of the selected inhibitor against AKAP5 was performed to validate the virtual screening results and the docking scores were in line with the virtual screening results. Cotreatment with 5-MTHF significantly increased cytotoxicity in 5637 cells treated with 2.5 μM of cisplatin, compared to the groups not receiving 5-MTHF (P

  • Doxorubicin and liposomal doxorubicin induce senescence by enhancing nuclear factor kappa B and mitochondrial membrane potential

    by Marjan Fallah, Hamidreza Mohammadi, Fatemeh Shaki, Zahra Hosseini-Khah, Milad Moloudizargari, Ayat Dashti, Ali Ziar, Abbas Mohammadpour, Atefeh Mirshafa, Mona Modanloo, et al.


  • NLRP inflammasome as a key role player in the pathogenesis of environmental toxicants

    by Milad Moloudizargari, Fatemeh Moradkhani, Narjes Asghari, Marjan Fallah, Mohammad Hossein Asghari, Ali Akbar Moghadamnia, Mohammad Abdollahi